Hi-Tech Pharmacal Co. (HITK) Beats Q4 Views on Top and Bottom
Tweet
Share
E-mailGet Alerts HITK Hot Sheet
Price: $43.49 --0%
Financial Fact:
Income tax expense: 3.96M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Income tax expense: 3.96M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Hi-Tech Pharmacal Co, Inc. (NASDAQ: HITK) reported Q4 EPS of $1.08, $0.37 better than the analyst estimate of $0.71. Revenue for the quarter came in at $57.2 million versus the consensus estimate of $49.33 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Marti Technologies (MRT) Misses Q2 EPS by 9c ; Offers Guidance
- TJX Cos. (TJX) Tops Q2 EPS by 3c, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
